100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human ARHGDIA/Rho GDP Dissociation Inhibitor Alpha ELISA Kit (HUFI02229)

SKU HUFI02229
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 0.094 ng/mL
Range 0.156-10 ng/mL
$857

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human ARHGDIA/Rho GDP Dissociation Inhibitor Alpha ELISA Kit

The Human ARHGDIA (Rho GDP Dissociation Inhibitor Alpha) ELISA Kit offered by Assay Genie is the perfect tool for researchers looking to accurately measure levels of ARHGDIA in human samples such as serum, plasma, and cell culture supernatants. This kit is known for its high sensitivity and specificity, ensuring dependable and consistent results for a variety of research applications. ARHGDIA is a key protein involved in regulating the Rho family of small GTPases, which play a critical role in cell signaling and cytoskeletal dynamics.

Dysregulation of ARHGDIA has been linked to various diseases such as cancer, immune disorders, and neurological conditions, making it a valuable biomarker for studying these diseases and potential therapeutic interventions. By using the Human ARHGDIA ELISA Kit from Assay Genie, researchers can uncover valuable insights into the role of ARHGDIA in disease pathology and progression, ultimately contributing to the development of novel treatment strategies.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose